Skip to main content
. 2009 Nov 7;25(2):345–353. doi: 10.1093/humrep/dep377

Table I.

Patient characteristics at recruitment, by randomized group

CDB-2914 (n = 69) Placebo (n = 67)
Age (years) at LNG-IUS insertion—Mean (SD) 36.9 (6.5) 35.8 (7.0)
Reported length (days) of most recent menstrual period—Mean (SD) 5.9 (1.7) 5.6 (1.5)
Length (days) of diary-screened menstrual cycle—Mean (SD) 28.8 (4.7) 28.0 (4.1)
Days prior to LNG-IUS insertion that most recent menstrual period started—Median (Q1, Q3) 12 (7, 19) 15 (10, 21)
IUD in situ at insertion visit—N (%) 5 (7) 9 (13)
Current smoker—N (%) 13 (19) 11 (16)
Employment—N (%)
 Full-time 30 (43) 32 (48)
 Part-time 28 (41) 26 (39)
 No job 11 (16) 8 (12)
Number of deliveries—N (%)
 0 14 (20) 20 (30)
 1 18 (26) 13 (19)
 2 30 (43) 27 (40)
 3 6 (9) 7 (10)
 4 1 (1) 0 (0)
Previous contraceptive method—N (%)
 Pill 4 (6) 3 (4)
 Cu-IUD 5 (7) 9 (13)
 Barrier—mainly condom* 53 (77) 52 (78)
 Rhythm/withdrawal/ spermicide 3 (4) 2 (3)
 None 4 (6) 1 (1)
Heaviness of menstrual periods in last 6 months—N (%)
 Light loss 2 (3) 0 (0)
 Moderate loss 25 (38) 25 (40)
 Heavy loss 26 (40) 29 (46)
 Very heavy loss 12 (18) 9 (14)
 Bleeding or spotting in quarter or more of menstrual cycles in past year—N/n (%) 10/66 (15) 10/62 (16)
Ever stopped using method of contraception due to following reason
 Unacceptable weight gain— N/n (%) 20/54 (37) 15/58 (26)
 Irregular bleeding or spotting—N/n (%) 16/53 (30) 12/57 (21)
 Unacceptably heavy bleeding—N/n (%) 10/51 (20) 6/57 (11)
 Periods stopped altogether— N/n (%) 1/48 (2) 1/57 (2)

*Includes the one woman (in Placebo group) who was using diaphragm.